In a recent study by Strell et al. performed on mammary ductal carcinoma in situ (DCIS) patient samples, authors found an association between high tissue expression of PDGFR‐β and reduced RT sensitivity, indicating a potential role of PDGFR‐β positive cells in radiotherapy resistance.55 Here, PDGFRB is linked to ductal breast carcinoma in situ.